Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Fish-oil Supplements May Reduce Anger in Substance Abusers
Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior.
- Fish-oil Supplements May Reduce Anger in Substance Abusers
Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior.
- Fish-oil Supplements May Reduce Anger in Substance Abusers
Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior.
- Fish-oil Supplements May Reduce Anger in Substance Abusers
Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior.
- Study Examines Chocolate Chip Cookie with Soluble Fiber, Plant Sterols, and Impact on Cholesterol
double-blind, placebo-controlled cross-over study indicates that specially formulated chocolate chip cookie containing soluble fiber and plant sterols led to a significant decrease in total cholesterol and LDL cholesterol in patients who ate two chocolate chip Right Direction Cookies(tm) each day for 30 days.
- Study Examines Chocolate Chip Cookie with Soluble Fiber, Plant Sterols, and Impact on Cholesterol
double-blind, placebo-controlled cross-over study indicates that specially formulated chocolate chip cookie containing soluble fiber and plant sterols led to a significant decrease in total cholesterol and LDL cholesterol in patients who ate two chocolate chip Right Direction Cookies(tm) each day for 30 days.
- Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects
Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day.
- Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects
Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day.
- Study Shows Standardized White Bean Extract Reduces the GI of White Bread
Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%.
- Study Shows Standardized White Bean Extract Reduces the GI of White Bread
Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%.
- ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans
Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake.
- ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans
Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake.
- ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans
Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake.
- ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans
Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- Eating More Than Five Portions Of Fruit And Vegetables a Day Can Substantially Reduce The Risk Of Stroke
UK researchers reveiwed data from eight studies involving over 257 500 people
from Europe, Japan, and the USA, observing that compared to individuals who have less than three fruit and vegetable servings a day, those with three to five servings per day had an 11% reduction in the incidence of stroke, while those with more than five servings per day had a relative reduction of 26%.
- Eating More Than Five Portions Of Fruit And Vegetables a Day Can Substantially Reduce The Risk Of Stroke
UK researchers reveiwed data from eight studies involving over 257 500 people
from Europe, Japan, and the USA, observing that compared to individuals who have less than three fruit and vegetable servings a day, those with three to five servings per day had an 11% reduction in the incidence of stroke, while those with more than five servings per day had a relative reduction of 26%.
- Tonalin® CLA Study Among 'Most Noteworthy' in ODS Annual Bibliography
Tonalin® CLA (conjugated linoleic acid) research documenting the long-term safety and efficacy of Tonalin® CLA supplementation, published in the American Journal of Clinical Nutrition (Gaullier J-M. et al., Am. J. Clin. Nutr., 2004; 79(6):1118-1125), was selected as one of 25 “exemplary” papers to appear in the National Institutes of Health (NIH) Office of Dietary Supplements’ (ODS) Annual Bibliography of Significant Advances in Dietary Supplement Research 2004.
- Tonalin® CLA Study Among 'Most Noteworthy' in ODS Annual Bibliography
Tonalin® CLA (conjugated linoleic acid) research documenting the long-term safety and efficacy of Tonalin® CLA supplementation, published in the American Journal of Clinical Nutrition (Gaullier J-M. et al., Am. J. Clin. Nutr., 2004; 79(6):1118-1125), was selected as one of 25 “exemplary” papers to appear in the National Institutes of Health (NIH) Office of Dietary Supplements’ (ODS) Annual Bibliography of Significant Advances in Dietary Supplement Research 2004.
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox
Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity.
- Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox
Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity.
- Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox
Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity.
- Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox
Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity.
- Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better
Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats.
- Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better
Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats.
- Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better
Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats.
- New Study On Saw Palmetto Demonstrates Puzzling Results
A new study on saw palmetto’s role in relieving symptoms of benign prostatic hyperplasia, published in the February 9 issue of the New England Journal of Medicine, showed inconsistent conclusions to those found in the existing body of scientific literature on the popular dietary supplement.
- New Study On Saw Palmetto Demonstrates Puzzling Results
A new study on saw palmetto’s role in relieving symptoms of benign prostatic hyperplasia, published in the February 9 issue of the New England Journal of Medicine, showed inconsistent conclusions to those found in the existing body of scientific literature on the popular dietary supplement.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD
dicentra Inc.™ will host a live web seminar on Wednesday, January 28, 2009 at 2 p.m. Eastern Standard Time outlining the challenges and solutions to registering a probiotic product as a natural health product with the Natural Health Products Directorate of Health Canada.
- What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges.
- What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges.
- What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges.
- What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges.
- What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges.
- What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges.
- What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges.
- What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges.
- What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges.
- Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs
Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack.
- Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs
Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack.
- Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs
Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack.
- Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs
Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack.
- Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs
Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack.
- Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs
Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack.
- Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here
- Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here
- Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here
- Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here
- Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here
- Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here
- Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here
- SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize
- SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize
- SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize
|
Lacey, WA – January 31, 2006 – Unigen Pharmaceuticals, Inc., a leading research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries, has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
Dr. O’Reilly joins Unigen with outstanding credentials, not only as an experienced board-certified physician, but as an experienced researcher, principal investigator, member of an Institutional Review Board (IRB), and an IRB staff physician. She has worked as a regulatory reviewer and trainer, medical director, and marketing executive, and has an extensive background in Phase I – IV human clinical studies.
“The hiring of Dr. O’Reilly to head up all of Unigen’s human clinical trials is a huge milestone for us,” said Dr. Qi Jia, Chief Scientific Officer for Unigen. “In the past three years, Unigen has completed eight human clinical trials for safety and efficacy for a number of products. This year, we will significantly increase our investment in human clinical studies to support products in our current and expanding product pipeline.”
Past human clinical trials have included products developed for oral consumption involving joint support, weight management and memory support. Clinical trials for products with topical application have included antioxidants and anti-aging cosmeceutical ingredients.
With Dr. O’Reilly onboard as a seasoned medical practitioner and clinical trials expert, Unigen is aggressively moving forward with its next series of human clinical trials that are currently underway. These include Seroctin™, a raw material ingredient that targets mood and anxiety, and a novel source of Policosanol that addresses healthy cholesterol levels. Studies for both products are currently being evaluated by the relevant IRBs (organizations that review proposals for clinical trials to ensure that the trial is ethical and that the rights of study participants are protected). Other human clinical trials planned for the near future will involve Unigen’s next generation of skin whitening ingredients, and the company’s recently launched ingredient, UniBEX™, that targets healthy blood circulation and blood lipid levels.
Prior to joining Unigen, Dr. O’Reilly worked for more than 10 years, most recently as Assistant Vice President, External Affairs, at the Western Institutional Review Board in Olympia. She has also worked as a Staff Physician and Investigator at the Middleton Foundation, and as a Medical Director and Principal Investigator at the Future Healthcare Research Center. Dr. O’Reilly has also served as a private practice and hospital-affiliated Physician.
Dr. O’Reilly received her M.D. from the Medical College of Wisconsin in Milwaukee, and her Bachelor of Science degree in biology, with Honors, at the University of Puget Sound in Tacoma, Washington. She completed a residency at the Tacoma Family Medicine center to become a Licensed Physician, Board-Certified in Family Practice.
Dr. O’Reilly’s past affiliations and accomplishments also include certification as an IRB Professional (CIP); memberships in the Drug Information Association (DIA), the American Society of Gene Therapy (ASGT), and the American Academy of Family Physicians; and serving as Chair of an Institutional Biosafety Committee (IBC) overseeing gene therapy research.
# # #
About Unigen Pharmaceuticals, Inc.
Unigen Pharmaceuticals, Inc. (www.UnigenPharma.com) is a leading natural products research and development company and proprietary ingredients supplier. The company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Its research and discovery process includes extensive work at both the human cell and gene level. Unigen and sister company Aloecorp, Inc. each focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary, patented raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.
Contact:
Regan Miles, President & Chief Operating Officer
360-486-8200 x1511
ReganMiles@earthlink.net
|